Drug allergy classification: Difference between revisions
No edit summary |
|||
Line 19: | Line 19: | ||
*Type III immune complex deposition: Delayed in onset and caused by IgG [[immune complex]] formation and deposition, and [[complement]] activation. | *Type III immune complex deposition: Delayed in onset and caused by IgG [[immune complex]] formation and deposition, and [[complement]] activation. | ||
*Type IV cell mediated/ delayed-type hypersensitivity reaction: [[T-cell]] mediated delayed onset reaction. | *Type IV cell mediated/ delayed-type hypersensitivity reaction: [[T-cell]] mediated delayed onset reaction. | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
Line 40: | Line 43: | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| ''' | | '''Type III immune complex deposition''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|Delayed in onset and caused by IgG [[immune complex]] formation and deposition, and [[complement]] activation. | ||
|bgcolor="Beige"| | |bgcolor="Beige"|Vasculitis, serum sickness, arthralgia, fever, rash | ||
|bgcolor="Beige"| | |bgcolor="Beige"|One to three weeks after exposure to drug | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| ''' | | '''Type IV cell mediated/ delayed-type hypersensitivity reaction''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|The presentation of drug molecules by [[major histocompatability complexes]] to [[T cells]], causing the release of cytokines and other inflammatory mediators. Also associated with the activation of eosinophils, monocytes, and neutrophils | ||
|bgcolor="Beige"| | |bgcolor="Beige"|Skin rashes, organ tissue damage, contact sensitivity | ||
|bgcolor="Beige"| | |bgcolor="Beige"|Two to seven days after exposure to a drug | ||
|- | |- | ||
|} | |} |
Revision as of 17:46, 16 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
Drug Allergy |
Diagnosis |
---|
Treatment |
Case Studies |
Drug allergy classification On the Web |
American Roentgen Ray Society Images of Drug allergy classification |
Risk calculators and risk factors for Drug allergy classification |
Overview
Drug allergies are classified using two main sets of criteria. One is set forth by the World Allergy Association, and classifies the reaction as to whether it occurs within one hour of treatment, or after one hour. The other set of criteria are based on the type of immunologic reaction that occurred and the mediators involved.
Classification Based on Timing of Symptoms
There are recommendations on the classification of drug allergy reactions based on the World Allergy Association (WAO) guidelines.[1] The two categories of classification are based on whether the reaction occurs less than one hour of medication administration, or more than one hour afterwards.
- Immediate- these reactions occur within one hour, and are most likely due to IgE mediated type I reactions. At times, type I reactions can occur after one hour if the absorption of the drug is delayed, for example due to an oral medication or ingesting a medication with food. These types of reactions have the risk of anaphylaxis if the patient is re-exposed.
- Delayed- these reactions occur after one hour, although most occur 6 hours after the administration of the drug, and some occur up to 7 to 10 days after treatment. Some reactions can even occur days after the treatment has been stopped.
Classification Based on Reaction Type
One type of classification of drug allergies, is based on the type of autoimmune process. This is the same type of classification that is used for other types of immunological reactions, and is based on the Gell and Coombs system. Drugs usually cause type III and type IV reactions, however certain medications such as penecillin, can cause all four.
- Type I hypersensitivity reaction/ IgE mediated: and primarily caused by the IgE, basophils, and degranulation of mast cells.
- Type II antibody mediated cell destruction: Delayed onset reaction caused by antibodies, mediated by IgG mediated destruction of cells.
- Type III immune complex deposition: Delayed in onset and caused by IgG immune complex formation and deposition, and complement activation.
- Type IV cell mediated/ delayed-type hypersensitivity reaction: T-cell mediated delayed onset reaction.
Immune Reaction | Mechanism of Action | Manifestations | Timing of Reaction |
Type I IgE mediated | Immediate onset caused by IgE binding to mast cells causing degranulation and release of histamine | Urticaria, anaphylaxis, angioedema, bronchospasm | Minutes or hours after drug ingestion |
Type II antibody mediated cell destruction/ cytotoxic | Delayed onset reaction caused by IgG or IgM antibodies, directed at drug-hapten coated cells | Thrombocytopenia, anemia, cytopenia | Variable |
Type III immune complex deposition | Delayed in onset and caused by IgG immune complex formation and deposition, and complement activation. | Vasculitis, serum sickness, arthralgia, fever, rash | One to three weeks after exposure to drug |
Type IV cell mediated/ delayed-type hypersensitivity reaction | The presentation of drug molecules by major histocompatability complexes to T cells, causing the release of cytokines and other inflammatory mediators. Also associated with the activation of eosinophils, monocytes, and neutrophils | Skin rashes, organ tissue damage, contact sensitivity | Two to seven days after exposure to a drug |